Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
申请公布号
CA2752129(A1)
申请公布日期
2010.08.19
申请号
CA20102752129
申请日期
2010.02.11
申请人
HOPE MEDICAL ENTERPRISE, INC. D.B.A. HOPE PHARMACEUTICALS
发明人
SHERMAN, CRAIG;LEPINE, ANTHONY JAMES;SMITH, CATHERINE MARIE;WIRTZ, KEVIN ROBERT;SCHULZE, ERICH